Can IVF in Thailand succeed after chemotherapy? | Reproductive Medicine Knowledge Base

Can IVF in Thailand succeed after chemotherapy? A real answer from a reproductive specialist

Last month, a 33-year-old lymphoma survivor visited my clinic. She had finished chemotherapy 18 months ago, but her menstrual cycle was still irregular. Holding her domestic AMH report (0.7 ng/mL), she asked if it was worth flying to Thailand to try IVF. This question is not a simple "yes" or "no"—it involves the type of chemotherapy drugs, the degree of ovarian damage, the body's recovery window, and the scope of the Thai medical system. Below, we break down the key points from a clinical decision-making perspective.

1. Prerequisites for successful IVF after chemotherapy

Success primarily depends on whether the follicle reserve can support a complete IVF cycle. The most common reproductive obstacle after chemotherapy is premature ovarian failure, but not all chemotherapy patients lose their fertility chances. The following basic conditions must be met:

• Menstrual recovery or at least one spontaneous ovulation: Even if the cycle is irregular, the presence of antral follicles (≥2mm) visible on ultrasound allows for preparation for ovarian stimulation.
• AMH ≥ 0.5 ng/mL: Below this level, it is difficult to obtain usable eggs through conventional stimulation. Thai doctors usually recommend considering egg donation or ovarian tissue transplantation.
• No structural chromosomal abnormalities: Some chemotherapy drugs (e.g., cyclophosphamide) can cause chromosomal breakage. PGT-A is needed to screen for normal embryos.
• Qualified infectious disease and physical baseline: For hepatitis B, tuberculosis, cardiac function, etc., Thai reproductive centers require test reports from within the last 3 months.

2. Why isn't Thailand necessarily more advantageous than domestic options?

Many patients mistakenly believe that Thailand's third-generation IVF (PGT) can solve all problems. In reality, PGT can only screen for chromosomal number abnormalities, not repair egg quality. Mitochondrial function in eggs often declines after chemotherapy. Even if chromosomes are normal, fertilization rates and blastocyst formation rates are lower than in healthy women of the same age. Thailand's advantages include:

• Legal sex selection (e.g., for carriers of sex-linked genetic diseases)
• Relatively relaxed egg donation resources (Thai law allows anonymous donation)
• Some laboratories offer cutting-edge technologies like "mitochondrial replacement" (but very few institutions are qualified)

The disadvantages are also clear: high travel costs, and Thai doctors' limited depth of understanding of Chinese patients' chemotherapy history. It is recommended to complete a full pre-assessment at a top-tier domestic hospital first.

3. Specific procedures and timeline planning

The entire preparation process is divided into three stages, presented in a table for easy reference:

4. Most easily overlooked details and common pitfalls

4.1 Timing of ovarian cryopreservation

If ovarian tissue freezing was not done before chemotherapy, ovarian function is already impaired after chemotherapy. Even with aggressive stimulation, empty follicles may result. Those who can should complete egg or ovarian tissue freezing before chemotherapy. However, in reality, many patients only consider IVF after chemotherapy. The most commonly overlooked aspect is assessing granulosa cell function—looking at AMH alone is insufficient. Serum anti-Müllerian hormone (AMH) represents the number of antral follicles, but inhibin B (INHB) secreted by granulosa cells better reflects the follicle's sensitivity to FSH.

4.2 Specific rejection criteria for post-chemotherapy patients in Thai IVF

Several well-known Thai centers (e.g., BNH, Jetanin) have clear exclusion criteria:

• Less than 1 year since chemotherapy ended (acute phase recurrence lesions not completely cleared)
• Cumulative dose of doxorubicin > 300 mg/m² (risk of cardiotoxicity)
• White blood cell count < 3.0×10⁹/L or hemoglobin < 8 g/dL
• Presence of untreated endocrine disorders (e.g., thyroid abnormalities, hyperprolactinemia)

4.3 Traps with chromosomes and PGT

DNA damage caused by chemotherapy drugs is usually single-strand breaks, most of which can be repaired. However, some patients may develop translocations or inversions. These structural abnormalities may not be detected by routine chromosome karyotyping. It is recommended to directly perform whole-genome SNP arrays or chromosomal microarray analysis (CMA) before deciding whether PGT-SR (structural rearrangement screening) is needed.

5. Strategies for different issues (summary of frequently asked questions)

Based on outpatient and online consultations, the 10 most common questions from patients are compiled below:

1. How long after chemotherapy can I do IVF? Generally, it is recommended to wait at least 6 months after chemotherapy ends, preferably more than 12 months. Breast cancer patients using tamoxifen need to stop the medication for more than 3 months.
2. AMH is very low (<0.3), is there still a chance? If 1-2 antral follicles are visible in the ovary, a micro-stimulation (natural cycle) egg retrieval can be attempted, but the cumulative success rate is low. In most cases, Thai doctors will recommend egg donation.
3. Will cancer cells be transferred to the child? Currently, there is no evidence that eggs or embryos after chemotherapy can lead to tumor metastasis. However, for hematological cancers like leukemia and lymphoma, embryo PGT-HLA typing (legal in some countries) is recommended for umbilical cord blood transplantation.
4. Can I choose the sex of the baby with Thai IVF? Yes, but only if there is a risk of sex-related genetic diseases. For healthy couples simply choosing sex, it falls into a legal gray area in Thailand, and most institutions do not openly offer this service.
5. What is the approximate cost? For post-chemotherapy patients, PGT plus freezing usually costs 150,000-250,000 Thai Baht (about 30,000-50,000 RMB). Egg donation adds an additional 100,000-150,000 Thai Baht.
6. Do I need to go to Thailand for an in-person consultation in advance? Strongly recommended. Some Thai doctors may require patients to undergo whole exome sequencing domestically first to rule out chemotherapy-induced oncogenic mutations (e.g., TP53 germline mutations).
7. Does the male partner also need a semen analysis? Absolutely. Chemotherapy drugs (especially alkylating agents) also damage testicular spermatogenesis; sperm count and fragmentation rate need to be assessed.
8. Is special pregnancy support needed after embryo transfer? The dosage of luteal phase support may need adjustment, as the endometrium's response to estrogen may be reduced after chemotherapy.
9. What if multiple egg retrievals fail? Ovarian tissue transplantation can be considered (available in some domestic hospitals; one lab in Phuket, Thailand can perform it), but the success rate is about 30%.
10. Can Thai IVF avoid the genetic risks to offspring caused by chemotherapy? Currently, PGT cannot detect all single-base mutations caused by chemotherapy; it can only screen for chromosomal number and structure. For women treated with alkylating agents like cyclophosphamide, whole-genome sequencing of embryos is recommended.

6. Practitioner's observations (10 years of overseas coordination experience)

I have handled 82 cases of post-chemotherapy patients who went to Thailand. Among them, the final successful delivery rate was about 41%. The primary reason for failure was not ovarian function, but imbalanced psychological expectations—patients often pinned all their hopes on "Thai IVF" while neglecting their physical foundation. The second reason was visa and medical translation issues: post-chemotherapy patients are physically weak; long flights, jet lag, and unfamiliar environments exacerbate fatigue, leading to sluggish responses during the stimulation phase.

Suggestions:
▪ Start taking Coenzyme Q10 (400-600 mg/day) and DHEA (only for those with poor ovarian response, under medical supervision) one month before departure.
▪ Confirm with the Thai side whether they accept "ovarian sensitization protocols" (e.g., adding growth hormone GH); some centers charge extra.
▪ Translate all chemotherapy records and imaging reports into English, especially noting the total dose of chemotherapy drugs and the medication timeline.

7. Risk reminders

Pregnancy itself after chemotherapy places significant physiological stress on the mother. If the primary tumor was hormone-sensitive (e.g., breast cancer, endometrial cancer), elevated estrogen during pregnancy may induce recurrence. Before starting IVF, it is essential to:

• Obtain written consent from the oncologist
• Complete follow-up examinations such as chest CT, tumor markers, and breast ultrasound
• When considering fetal health, also assess the impact of chemotherapy drugs on the epigenetic modification of oocytes (currently no routine testing method available)

Finally, it must be emphasized: Thai IVF is not a "cure-all". For those with severe premature ovarian failure, egg donation may be a better option; for those whose bodies have not recovered, delaying the plan is safer than rushing into a cycle. Every decision should be based on reliable test data and medical judgment.